{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:57:20Z","timestamp":1775732240577,"version":"3.50.1"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12325-026-03521-7","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T10:23:45Z","timestamp":1772533425000},"page":"1423-1438","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Critical Role of Oxygen Supplementation in Epithelium-On Corneal Cross-Linking: A Narrative Review"],"prefix":"10.1007","volume":"43","author":[{"given":"Christopher J.","family":"Rapuano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth A.","family":"Beckman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Rajpal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"issue":"3","key":"3521_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2021.101559","volume":"45","author":"J Santodomingo-Rubido","year":"2022","unstructured":"Santodomingo-Rubido J, Carracedo G, Suzaki A, Villa-Collar C, Vincent SJ, Wolffsohn JS. Keratoconus: an updated review. Cont Lens Anterior Eye. 2022;45(3):101559.","journal-title":"Cont Lens Anterior Eye"},{"issue":"4","key":"3521_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0039-6257(97)00119-7","volume":"42","author":"YS Rabinowitz","year":"1998","unstructured":"Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42(4):297\u2013319.","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"3521_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0039-6257(84)90094-8","volume":"28","author":"JH Krachmer","year":"1984","unstructured":"Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol. 1984;28(4):293\u2013322.","journal-title":"Surv Ophthalmol"},{"key":"3521_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1208911","volume":"10","author":"H Al Zabadi","year":"2023","unstructured":"Al Zabadi H, Shehadeh M, Amro L, Ghattass N, Taha I. Vision-related quality of life among patients with keratoconus: a cross sectional study. Front Med Lausanne. 2023;10:1208911.","journal-title":"Front Med Lausanne"},{"key":"3521_CR5","doi-asserted-by":"crossref","unstructured":"Al-Dairi W, Al Dehailan AM, Alhammadi Y, et al. Vision-Related Quality of Life in Patients With Keratoconus: A Nationwide Study in Saudi Arabia. Cureus. 2023;15(2).","DOI":"10.7759\/cureus.35178"},{"issue":"16","key":"3521_CR6","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1038\/s41433-024-03251-6","volume":"38","author":"L Fan","year":"2024","unstructured":"Fan L, Kandel H, Watson SL. Impacts of keratoconus on quality of life: a qualitative study. Eye Lond. 2024;38(16):3136\u201344.","journal-title":"Eye Lond"},{"key":"3521_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ajo.2023.11.009","volume":"259","author":"RB Singh","year":"2024","unstructured":"Singh RB, Parmar UPS, Jhanji V. Prevalence and economic burden of keratoconus in the United States. Am J Ophthalmol. 2024;259:71\u20138.","journal-title":"Am J Ophthalmol"},{"issue":"1\u20132","key":"3521_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5005\/jp-journals-10025-1195","volume":"10","author":"R Al Saidi","year":"2024","unstructured":"Al Saidi R, Almahroqi H, Bandara A, Deschmukh D. Prevalence of Keratoconus among Young Adults in Oman: A Cross-sectional Study Using Retinoscopy and Corneal Tomography. Int J Keratoconus Ectatic Corneal Dis. 2024;10(1\u20132):20\u20135.","journal-title":"Int J Keratoconus Ectatic Corneal Dis"},{"issue":"2","key":"3521_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000002150","volume":"39","author":"H Hashemi","year":"2020","unstructured":"Hashemi H, Heydarian S, Hooshmand E, et al. The prevalence and risk factors for keratoconus: a systematic review and meta-analysis. Cornea. 2020;39(2):263.","journal-title":"Cornea"},{"key":"3521_CR10","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.2147\/OPTH.S392665","volume":"17","author":"AD Bui","year":"2023","unstructured":"Bui AD, Truong A, Pasricha ND, Indaram M. Keratoconus diagnosis and treatment: recent advances and future directions. Clin Ophthalmol. 2023;17:2705\u201318.","journal-title":"Clin Ophthalmol"},{"key":"3521_CR11","unstructured":"Asimellis G, Kaufman EJ. Keratoconus. StatPearls [Internet]. Updated April 12, 2024. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470435\/"},{"issue":"5","key":"3521_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15050626","volume":"15","author":"TS Bahar","year":"2025","unstructured":"Bahar TS, \u015eahin V, Ayaz Y, \u00dcnal M. Long-term outcomes in crosslinking therapy for patients with progressive keratoconus. Diagnostics. 2025;15(5):626.","journal-title":"Diagnostics"},{"issue":"7","key":"3521_CR13","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1097\/j.jcrs.0000000000001442","volume":"50","author":"S Elving","year":"2024","unstructured":"Elving S, Fredriksson A, Beckman Rehnman J, Behndig A. Randomized clinical trial comparing customized corneal crosslinking: epi-on in high oxygen and epi-off in room air for keratoconus. J Cataract Refract Surg. 2024;50(7):746\u201353.","journal-title":"J Cataract Refract Surg"},{"key":"3521_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1198246","volume":"10","author":"C Mazzotta","year":"2023","unstructured":"Mazzotta C, Pandolfi A, Ferrise M. Progressive high-fluence epithelium-on accelerated corneal crosslinking: a novel corneal photodynamic therapy for early progressive keratoconus. Front Med (Lausanne). 2023;10:1198246.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"3521_CR15","doi-asserted-by":"publisher","first-page":"P170","DOI":"10.1016\/j.ophtha.2018.10.021","volume":"126","author":"FJ Garcia-Ferrer","year":"2019","unstructured":"Garcia-Ferrer FJ, Akpek EK, Amescua G, et al. Corneal Ectasia Preferred Practice Pattern\u00ae. Ophthalmology. 2019;126(1):P170\u2013215.","journal-title":"Ophthalmology"},{"issue":"9","key":"3521_CR16","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.ophtha.2017.03.052","volume":"124","author":"PS Hersh","year":"2017","unstructured":"Hersh PS, Stulting RD, Muller D, et al. United States multicenter clinical trial of corneal collagen crosslinking for keratoconus treatment. Ophthalmology. 2017;124(9):1259\u201370.","journal-title":"Ophthalmology"},{"issue":"4","key":"3521_CR17","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ophtha.2013.10.028","volume":"121","author":"C Wittig-Silva","year":"2014","unstructured":"Wittig-Silva C, Chan E, Islam FMA, Wu T, Whiting M, Snibson GR. A randomized, controlled trial of corneal collagen cross-linking in progressive keratoconus: Three-year results. Ophthalmology. 2014;121(4):812\u201321.","journal-title":"Ophthalmology"},{"issue":"1","key":"3521_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jcrs.2014.09.033","volume":"41","author":"F Raiskup","year":"2015","unstructured":"Raiskup F, Theuring A, Pillunat LE, Spoerl E. Corneal collagen crosslinking with riboflavin and ultraviolet-A light in progressive keratoconus: ten-year results. J Cataract Refract Surg. 2015;41(1):41\u20136.","journal-title":"J Cataract Refract Surg"},{"issue":"4","key":"3521_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/ICO.0000000000000408","volume":"34","author":"JAP Gomes","year":"2015","unstructured":"Gomes JAP, Tan D, Rapuano CJ, et al. Global consensus on keratoconus and ectatic diseases. Cornea. 2015;34(4):359\u201369.","journal-title":"Cornea"},{"key":"3521_CR20","doi-asserted-by":"crossref","unstructured":"Farhad Hafezi, Mark Hillen, L\u00e9onard Kollros, Nikki Hafezi EATN. Corneal cross-linking in thin corneas: From origins to state of the art. touchREVIEWS in Ophthalmology. 2022;16(1):13\u201316.","DOI":"10.17925\/USOR.2022.16.1.13"},{"issue":"5","key":"3521_CR21","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0002-9394(02)02220-1","volume":"135","author":"G Wollensak","year":"2003","unstructured":"Wollensak G, Spoerl E, Seiler T. Riboflavin\/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620\u20137.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"3521_CR22","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1167\/iovs.13-13748","volume":"55","author":"A Hammer","year":"2014","unstructured":"Hammer A, Richoz O, Mosquera SA, Tabibian D, Hoogewoud F, Hafezi F. Corneal biomechanical properties at different corneal cross-linking (CXL) irradiances. Invest Ophthalmol Vis Sci. 2014;55(5):2881\u20134.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"08","key":"3521_CR23","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.jcrs.2017.05.036","volume":"43","author":"E Toker","year":"2017","unstructured":"Toker E, \u00c7erman E, \u00d6zcan D\u00d6 S\u00d6. Efficacy of different accelerated corneal crosslinking protocols for progressive keratoconus. J Cataract Refract Surg. 2017;43(08):1089\u201399.","journal-title":"J Cataract Refract Surg"},{"issue":"4","key":"3521_CR24","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1167\/iovs.11-9385","volume":"53","author":"P Kamaev","year":"2012","unstructured":"Kamaev P, Friedman MD, Sherr E, Muller D. Photochemical kinetics of corneal cross-linking with riboflavin. Invest Ophthalmol Vis Sci. 2012;53(4):2360\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"3521_CR25","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.2.7.6","volume":"2","author":"O Richoz","year":"2013","unstructured":"Richoz O, Hammer A, Tabibian D, Gatzioufas Z, Hafezi F. The biomechanical effect of corneal collagen cross-linking (CXL) with riboflavin and UV-A is oxygen dependent. Transl Vis Sci Technol. 2013;2(7):6.","journal-title":"Transl Vis Sci Technol"},{"issue":"5","key":"3521_CR26","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/ICL.0000000000000645","volume":"46","author":"J Wang","year":"2020","unstructured":"Wang J, Wang L, Li Z, Wang YM, Zhu K, Mu G. Corneal biomechanical evaluation after conventional corneal crosslinking with oxygen enrichment. Eye Contact Lens. 2020;46(5):306\u20139.","journal-title":"Eye Contact Lens"},{"issue":"5","key":"3521_CR27","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/j.jcrs.0000000000000488","volume":"47","author":"MJ Kang","year":"2021","unstructured":"Kang MJ, Hwang J, Chung SH. Comparison of pulsed and continuous accelerated corneal crosslinking for keratoconus: 1-year results at a single center. J Cataract Refract Surg. 2021;47(5):641\u20138.","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"3521_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00417-024-06622-7","volume":"263","author":"M Qureshi","year":"2025","unstructured":"Qureshi M, Watson SL, Kandel H. Pulsed corneal crosslinking in the treatment of Keratoconus: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2025;263(3):589\u2013601.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"3521_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/17469899.2023.2207010","volume":"18","author":"C Mazzotta","year":"2023","unstructured":"Mazzotta C, Pulvirenti MA, Zagari M, Jihad S, Armia Balamoun A. Crosslinking for progressive keratoconus: is there room for improvement? Expert Rev Ophthalmol. 2023;18(2):121\u201333.","journal-title":"Expert Rev Ophthalmol"},{"key":"3521_CR30","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.2147\/OPTH.S508618","volume":"19","author":"RO Nughays","year":"2025","unstructured":"Nughays RO, Bazayd AS, Alshamekh LA, et al. Efficacy and safety of epi-on vs epi-off corneal cross-linking in corneal ectasia: a systematic review and meta-analysis of randomized controlled trials. Clin Ophthalmol. 2025;19:1531\u201341.","journal-title":"Clin Ophthalmol"},{"key":"3521_CR31","doi-asserted-by":"crossref","unstructured":"Akram S, Momin S, Malik B, Sirang Z. Outcomes of epi-on collagen cross-linkage procedure assessed in progressive keratoconus patients. Cureus. 2022;14(10).","DOI":"10.7759\/cureus.30664"},{"issue":"4","key":"3521_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/02713683.2021.2018466","volume":"47","author":"K Abe","year":"2022","unstructured":"Abe K, Miyai T, Toyono T, et al. Comparison of efficacy and safety of accelerated trans-epithelial crosslinking for keratoconus patients with corneas thicker and thinner than 380\u03bcm. Curr Eye Res. 2022;47(4):511\u20136.","journal-title":"Curr Eye Res"},{"issue":"8","key":"3521_CR33","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.jcrs.2013.03.026","volume":"39","author":"A Caporossi","year":"2013","unstructured":"Caporossi A, Mazzotta C, Paradiso AL, Baiocchi S, Marigliani D, Caporossi T. Transepithelial corneal collagen crosslinking for progressive keratoconus: 24-month clinical results. J Cataract Refract Surg. 2013;39(8):1157\u201363.","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"3521_CR34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/j.jcrs.0000000000001339","volume":"50","author":"B Cronin","year":"2024","unstructured":"Cronin B, Gunn D, Chang CY. Oxygen-supplemented and topography-guided epithelium-on corneal crosslinking with pulsed irradiation for progressive keratoconus. J Cataract Refract Surg. 2024;50(3):209\u201316.","journal-title":"J Cataract Refract Surg"},{"issue":"10","key":"3521_CR35","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1097\/j.jcrs.0000000000000952","volume":"48","author":"B Cronin","year":"2022","unstructured":"Cronin B, Ghosh A, Chang CY. Oxygen-supplemented transepithelial-accelerated corneal crosslinking with pulsed irradiation for progressive keratoconus: 1 year outcomes. J Cataract Refract Surg. 2022;48(10):1175\u201382.","journal-title":"J Cataract Refract Surg"},{"key":"3521_CR36","first-page":"1","volume":"12","author":"D Wu","year":"2021","unstructured":"Wu D, Lim DKA, Lim BXH, et al. Corneal cross-linking: the evolution of treatment for corneal diseases. Front Pharmacol. 2021;12:1\u201319.","journal-title":"Front Pharmacol"},{"issue":"5","key":"3521_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm14051702","volume":"14","author":"N Papachristoforou","year":"2025","unstructured":"Papachristoforou N, Ueno A, Ledwos K, Bartu\u015b J, Nowi\u0144ska A, Karska-Basta I. A review of keratoconus cross-linking treatment methods. J Clin Med. 2025;14(5):1\u201318.","journal-title":"J Clin Med"},{"issue":"1","key":"3521_CR38","first-page":"44","volume":"14","author":"A Naranjo","year":"2024","unstructured":"Naranjo A, Manche EE. A comprehensive review on corneal crosslinking. Taiwan J Ophthalmol. 2024;14(1):44\u20139.","journal-title":"Taiwan J Ophthalmol"},{"key":"3521_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1232591","volume":"14","author":"D Qin","year":"2023","unstructured":"Qin D, Han Y, Wang L, Yin H. Recent advances in medicinal compounds related to corneal crosslinking. Front Pharmacol. 2023;14:1232591.","journal-title":"Front Pharmacol"},{"issue":"15","key":"3521_CR40","doi-asserted-by":"publisher","first-page":"13011","DOI":"10.1074\/jbc.M110.169813","volume":"286","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Conrad AH, Conrad GW. Effects of ultraviolet-A and riboflavin on the interaction of collagen and proteoglycans during corneal cross-linking. J Biol Chem. 2011;286(15):13011\u201322.","journal-title":"J Biol Chem"},{"key":"3521_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2024.101322","volume":"104","author":"F Hafezi","year":"2025","unstructured":"Hafezi F, Kling S, Hafezi NL, et al. Corneal cross-linking. Prog Retin Eye Res. 2025;104:101322.","journal-title":"Prog Retin Eye Res"},{"key":"3521_CR42","doi-asserted-by":"crossref","unstructured":"Raiskup F, Herber R, Lenk J, Pillunat LE, Spoerl E. Crosslinking with UV-A and riboflavin in progressive keratoconus: From laboratory to clinical practice \u2013 Developments over 25 years. Prog Retin Eye Res. 2024;102(May).","DOI":"10.1016\/j.preteyeres.2024.101276"},{"issue":"1","key":"3521_CR43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3928\/1081597X-20201111-01","volume":"37","author":"A Matthys","year":"2021","unstructured":"Matthys A, Cassagne M, Galiacy SD, El Hout S, Fourni\u00e9 P, Malecaze F. Transepithelial corneal cross-linking with supplemental oxygen in keratoconus: 1-year clinical results. J Refract Surg. 2021;37(1):42\u20138.","journal-title":"J Refract Surg"},{"issue":"1","key":"3521_CR44","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1167\/iovs.09-3738","volume":"51","author":"A Scott McCall","year":"2010","unstructured":"Scott McCall A, Kraft S, Edelhauser HF, et al. Mechanisms of corneal tissue cross-linking in response to treatment with topical riboflavin and long-wavelength ultraviolet radiation (UVA). Invest Ophthalmol Vis Sci. 2010;51(1):129\u201338.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"3521_CR45","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/APO.0000000000000557","volume":"11","author":"L Angelo","year":"2022","unstructured":"Angelo L, Gokul Boptom A, McGhee C, Ziaei M. Corneal crosslinking: present and future. Asia Pac J Ophthalmol. 2022;11(5):441\u201352.","journal-title":"Asia Pac J Ophthalmol"},{"issue":"2","key":"3521_CR46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jtos.2013.01.002","volume":"11","author":"F Raiskup","year":"2013","unstructured":"Raiskup F, Spoerl E. Corneal crosslinking with riboflavin and ultraviolet A. I. principles. Ocul Surf. 2013;11(2):65\u201374.","journal-title":"Ocul Surf"},{"issue":"1","key":"3521_CR47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/exer.1997.0410","volume":"66","author":"E Spoerl","year":"1998","unstructured":"Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res. 1998;66(1):97\u2013103.","journal-title":"Exp Eye Res"},{"issue":"1","key":"3521_CR48","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/02713680490513182","volume":"29","author":"E Spoerl","year":"2004","unstructured":"Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res. 2004;29(1):35\u201340.","journal-title":"Curr Eye Res"},{"issue":"5","key":"3521_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/tvst.12.5.18","volume":"12","author":"M Kowalska","year":"2023","unstructured":"Kowalska M, Mischi E, Stoma S, N\u00f8rrelykke SF, Hartnack S, Pot SA. How modifications of corneal cross-linking protocols influence corneal resistance to enzymatic digestion and treatment depth. Transl Vis Sci Technol. 2023;12(5):9\u201315.","journal-title":"Transl Vis Sci Technol"},{"issue":"11","key":"3521_CR50","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1038\/s41433-021-01731-7","volume":"35","author":"U Ercin","year":"2021","unstructured":"Ercin U, Aribas YK, Tefon Aribas AB, Bilgihan A, Bilgihan K. Singlet oxygen formation during accelerated and hyperaccelerated corneal cross-linking: in vitro study. Eye Lond. 2021;35(11):3147\u201351.","journal-title":"Eye Lond"},{"issue":"1","key":"3521_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-025-03617-z","volume":"45","author":"L Krungkraipetch","year":"2025","unstructured":"Krungkraipetch L, Assawaboonyadech A, Supajitgulchai D. Corneal biomechanical property changes following corneal collagen cross-linking in keratoconus: a systematic review and meta-regression analysis. Int Ophthalmol. 2025;45(1):270.","journal-title":"Int Ophthalmol"},{"key":"3521_CR52","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ajo.2020.11.001","volume":"223","author":"TG Seiler","year":"2021","unstructured":"Seiler TG, Komninou MA, Nambiar MH, Schuerch K, Frueh BE, B\u00fcchler P. Oxygen kinetics during corneal cross-linking with and without supplementary oxygen. Am J Ophthalmol. 2021;223:368\u201376.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"3521_CR53","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1080\/02713683.2019.1669663","volume":"45","author":"J Hill","year":"2020","unstructured":"Hill J, Liu C, Deardorff P, et al. Optimization of oxygen dynamics, UV-A delivery, and drug formulation for accelerated epi-on corneal crosslinking. Curr Eye Res. 2020;45(4):450\u20138.","journal-title":"Curr Eye Res"},{"issue":"1","key":"3521_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/18743641-v16-e2207130","volume":"16","author":"JQH Choo","year":"2022","unstructured":"Choo JQH, Lim L. Transepithelial corneal cross-linking with supplemental oxygen in keratoconus treatment - corneal stromal demarcation line and safety. Open Ophthalmol J. 2022;16(1):1\u20137.","journal-title":"Open Ophthalmol J"},{"issue":"12","key":"3521_CR55","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1097\/j.jcrs.0000000000000347","volume":"46","author":"C Mazzotta","year":"2020","unstructured":"Mazzotta C, Sgheri A, Bagaglia SA, Rechichi M, Di Maggio A. Customized corneal crosslinking for treatment of progressive keratoconus: clinical and OCT outcomes using a transepithelial approach with supplemental oxygen. J Cataract Refract Surg. 2020;46(12):1582\u20137.","journal-title":"J Cataract Refract Surg"},{"issue":"6","key":"3521_CR56","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1007\/s10792-017-0762-5","volume":"38","author":"L Sun","year":"2018","unstructured":"Sun L, Li M, Zhang X, et al. Transepithelial accelerated corneal collagen cross-linking with higher oxygen availability for keratoconus: 1-year results. Int Ophthalmol. 2018;38(6):2509\u201317.","journal-title":"Int Ophthalmol"},{"issue":"5","key":"3521_CR57","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/APO.0000000000000555","volume":"11","author":"GA Borchert","year":"2022","unstructured":"Borchert GA, Watson SL, Kandel H. Oxygen in corneal collagen crosslinking to treat keratoconus: a systematic review and meta-analysis. Asia-Pac J Ophthalmol. 2022;11(5):453\u20139.","journal-title":"Asia-Pac J Ophthalmol"},{"issue":"3","key":"3521_CR58","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00417-024-06622-7","volume":"263","author":"M Qureshi","year":"2024","unstructured":"Qureshi M, Watson SL, Kandel H. Pulsed corneal crosslinking in the treatment of Keratoconus: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2024;263(3):589\u2013601.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"3521_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9103222","volume":"9","author":"K Kamiya","year":"2020","unstructured":"Kamiya K, Kanayama S, Takahashi M, Shoji N. Visual and topographic improvement with epithelium-on, oxygen-supplemented, customized corneal cross-linking for progressive keratoconus. J Clin Med. 2020;9(10):1\u201310.","journal-title":"J Clin Med"},{"issue":"9","key":"3521_CR60","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1007\/s10792-021-01859-1","volume":"41","author":"E Ayd\u0131n","year":"2021","unstructured":"Ayd\u0131n E, Aslan MG. The efficiency and safety of oxygen-supplemented accelerated transepithelial corneal cross-linking. Int Ophthalmol. 2021;41(9):2993\u20133005.","journal-title":"Int Ophthalmol"},{"issue":"6","key":"3521_CR61","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/j.jcrs.0000000000000513","volume":"47","author":"A Faramarzi","year":"2021","unstructured":"Faramarzi A, Hassanpour K, Rahmani B, Yazdani S, Kheiri B, Sadoughi MM. Systemic supplemental oxygen therapy during accelerated corneal crosslinking for progressive keratoconus: randomized clinical trial. J Cataract Refract Surg. 2021;47(6):773\u20139.","journal-title":"J Cataract Refract Surg"},{"key":"3521_CR62","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.2147\/OPTH.S409178","volume":"17","author":"MO Yousif","year":"2023","unstructured":"Yousif MO, Elkitkat RS, Alaarag NA, Seleet MM, Soliman AH. Comparison between pulsed and continuous accelerated corneal cross-linking protocols. Clin Ophthalmol. 2023;17:1407\u201313.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"3521_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/tvst.14.4.13","volume":"14","author":"J Menzel-Severing","year":"2025","unstructured":"Menzel-Severing J, Streit T, Schmiedel J, et al. Hyperbaric Oxygenation Increases Available Oxygen and Resistance to Enzymatic Digestion in Accelerated Corneal Collagen Crosslinking. Transl Vis Sci Technol. 2025;14(4):1\u201310.","journal-title":"Transl Vis Sci Technol"},{"issue":"1--2","key":"3521_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5005\/jp-journals-10025-1197","volume":"10","author":"R Al Saidi","year":"2024","unstructured":"Al Saidi R. Transepithelial (Epi-on) corneal collagen cross-linking with supplemental oxygen as a treatment for patients with progressive keratoconus in Oman: 1-year results. Int J Keratoconus Ectatic Corneal Dis. 2024;10(1--2):1\u20137.","journal-title":"Int J Keratoconus Ectatic Corneal Dis"},{"issue":"6","key":"3521_CR65","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s00417-023-06287-8","volume":"262","author":"GA Borchert","year":"2024","unstructured":"Borchert GA, Kandel H, Watson SL. Epithelium-on versus epithelium-off corneal collagen crosslinking for keratoconus: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2024;262(6):1683\u201392.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3521_CR66","doi-asserted-by":"crossref","unstructured":"Ng SM, Ren M, Lindsley KB, Hawkins BS, Kuo IC. Transepithelial versus epithelium-off corneal crosslinking for progressive keratoconus. Cochrane Database Syst Rev. 2021;3(3):CD013512.","DOI":"10.1002\/14651858.CD013512.pub2"},{"issue":"8","key":"3521_CR67","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1097\/ICO.0000000000001632","volume":"37","author":"D Wen","year":"2018","unstructured":"Wen D, Song B, Li Q, et al. Comparison of epithelium-off versus transepithelial corneal collagen cross-linking for keratoconus: a systematic review and meta-analysis. Cornea. 2018;37(8):1018\u201324.","journal-title":"Cornea"},{"issue":"4","key":"3521_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195105","volume":"13","author":"X Zhang","year":"2018","unstructured":"Zhang X, Zhao J, Li M, Tian M, Shen Y, Zhou X. Conventional and transepithelial corneal cross-linking for patients with keratoconus. PLoS ONE. 2018;13(4):e0195105.","journal-title":"PLoS ONE"},{"key":"3521_CR69","unstructured":"Glaukos Corp. Glaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa\u2122, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and Safety [Press release]. 2024. Available at: https:\/\/investors.glaukos.com\/news\/news-details\/2024\/Glaukos-Announces-Positive-Topline-Outcomes-in-Phase-3-Confirmatory-Trial-for-Epioxa-Achieving-Primary-Efficacy-Endpoint-and-Demonstrating-Favorable-Tolerability-and-Safety\/default.aspx. Accessed January 15, 2026"},{"issue":"4","key":"3521_CR70","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/ICO.0b013e3180334f78","volume":"26","author":"E Spoerl","year":"2007","unstructured":"Spoerl E, Mrochen M, Sliney D, Trokel S, Seiler T. Safety of UVA-riboflavin cross-linking of the cornea. Cornea. 2007;26(4):385\u20139.","journal-title":"Cornea"},{"key":"3521_CR71","doi-asserted-by":"crossref","unstructured":"Hwang B, Acharya B, Tomaiuolo M, et al. Rates and Risk Factors for Failure After Corneal Collagen Crosslinking for Keratoconus: An IRIS Registry Analysis.\u00a0Cornea. Published online September 25, 2025.","DOI":"10.1097\/ICO.0000000000003970"},{"issue":"12","key":"3521_CR72","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3928\/1081597X-20210830-01","volume":"37","author":"J Lenk","year":"2021","unstructured":"Lenk J, Herber R, Oswald C, Spoerl E, Pillunat LE, Raiskup F. Risk factors for progression of keratoconus and failure rate after corneal cross-linking. J Refract Surg. 2021;37(12):816\u201323.","journal-title":"J Refract Surg"},{"issue":"5","key":"3521_CR73","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1136\/bjo-2023-323391","volume":"108","author":"D Maskill","year":"2024","unstructured":"Maskill D, Okonkwo A, Onsiong C, Hristova S, Dodd A, Anand S. Repeat corneal collagen cross-linking after failure of primary cross-linking in keratoconus. Br J Ophthalmol. 2024;108(5):662\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"3521_CR74","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1080\/13696998.2025.2564576","volume":"28","author":"CJ Rapuano","year":"2025","unstructured":"Rapuano CJ, Lindstrom RL, Donnenfeld E, et al. Economics of corneal cross-linking for keratoconus treatment. J Med Econ. 2025;28(1):1696\u2013708.","journal-title":"J Med Econ"},{"key":"3521_CR75","unstructured":"Raizman M. A new era in keratoconus management. Cataract & Refractive Surgery Today. 2025:38\u201339."},{"key":"3521_CR76","doi-asserted-by":"crossref","unstructured":"D'Oria F, Palaz\u00f3n A, Alio JL. Corneal collagen cross-linking epithelium-on vs. epithelium-off: a systematic review and meta-analysis.\u00a0Eye Vis (Lond). 2021;8(1):34.","DOI":"10.1186\/s40662-021-00256-0"},{"key":"3521_CR77","unstructured":"Glaukos Corporation.\u00a0Highlights of Prescribing Information\u00a0EPIOXA HD 0.239% and EPIOXA 0.177%. U.S. Food and Drug Administration. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/219910s000lbl.pdf. Published October 2025. Accessed January 22, 2026."},{"key":"3521_CR78","doi-asserted-by":"crossref","unstructured":"Hafezi F. Transforming the eye with a new standard for corneal cross-linking. Ophthalmology Times. 2024;49(9).","DOI":"10.1201\/9781003523314"},{"key":"3521_CR79","first-page":"1","volume":"10","author":"R Deshmukh","year":"2023","unstructured":"Deshmukh R, Ong ZZ, Rampat R, et al. Management of keratoconus: an updated review. Front Med (Lausanne). 2023;10:1\u201326.","journal-title":"Front Med (Lausanne)"},{"key":"3521_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2024.1380701","volume":"4","author":"D Goodman","year":"2024","unstructured":"Goodman D, Zhu AY. Utility of artificial intelligence in the diagnosis and management of keratoconus: a systematic review. Front Ophthalmol (Lausanne). 2024;4:1380701.","journal-title":"Front Ophthalmol (Lausanne)"},{"issue":"6","key":"3521_CR81","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3928\/1081597X-20150521-04","volume":"31","author":"GK Marino","year":"2015","unstructured":"Marino GK, Torricelli AAM, Giacomin N, Santhiago MR, Espindola R, Netto MV. Accelerated corneal collagen cross-linking for postoperative LASIK ectasia: two-year outcomes. J Refract Surg. 2015;31(6):380\u20134.","journal-title":"J Refract Surg"},{"issue":"June","key":"3521_CR82","first-page":"1","volume":"42","author":"JB Margines","year":"2023","unstructured":"Margines JB, Rabinowitz YS, Li X, Gaster RN. Results of corneal collagen cross-linking in patients with corneal ectasia after laser refractive surgery\u2014a prospective study. Photodiagnosis Photodyn Ther. 2023;42(June):1\u20136.","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"11","key":"3521_CR83","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.ophtha.2017.05.012","volume":"124","author":"A Austin","year":"2017","unstructured":"Austin A, Lietman T, Rose-Nussbaumer J. Update on the management of infectious keratitis. Ophthalmology. 2017;124(11):1678\u201389.","journal-title":"Ophthalmology"},{"issue":"1","key":"3521_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40662-021-00272-0","volume":"9","author":"F Hafezi","year":"2022","unstructured":"Hafezi F, Hosny M, Shetty R, et al. PACK-CXL vs. antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: a prospective randomized phase 3 trial. Eye Vis. 2022;9(1):1\u201311.","journal-title":"Eye Vis"},{"issue":"8","key":"3521_CR85","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4103\/0301-4738.116068","volume":"61","author":"J Vazirani","year":"2013","unstructured":"Vazirani J, Vaddavalli PK. Cross-linking for microbial keratitis. Indian J Ophthalmol. 2013;61(8):441\u20134.","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"3521_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-024-08011-1","volume":"25","author":"J Wiedemann","year":"2024","unstructured":"Wiedemann J, Hos D, Limburg E, et al. UV light-mediated corneal crosslinking as (lymph)angioregressive pretreatment to promote graft survival after subsequent high-risk corneal transplantation (CrossCornealVision): protocol for a multicenter, randomized controlled trial. Trials. 2024;25(1):1\u201315.","journal-title":"Trials"},{"issue":"12","key":"3521_CR87","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1111\/ajt.14874","volume":"18","author":"Y Hou","year":"2018","unstructured":"Hou Y, Le VNH, T\u00f3th G, et al. UV light crosslinking regresses mature corneal blood and lymphatic vessels and promotes subsequent high-risk corneal transplant survival. Am J Transplant. 2018;18(12):2873\u201384.","journal-title":"Am J Transplant"},{"issue":"5","key":"3521_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2025.100816","volume":"5","author":"AM Roldan","year":"2025","unstructured":"Roldan AM, Singh RB, De Arrigunaga S, et al. Clinical efficacy of ex vivo cross-linking on neovascularization of the donor cornea carrier tissue for the Boston type I keratoprosthesis. Ophthalmology Science. 2025;5(5):100816.","journal-title":"Ophthalmology Science"},{"issue":"2","key":"3521_CR89","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/ICO.0000000000002406","volume":"40","author":"F Schaub","year":"2021","unstructured":"Schaub F, Hou Y, Zhang W, Bock F, Hos D, Cursiefen C. Corneal crosslinking to regress pathologic corneal neovascularization before high-risk keratoplasty. Cornea. 2021;40(2):147\u201355.","journal-title":"Cornea"},{"issue":"12","key":"3521_CR90","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.ophtha.2013.07.038","volume":"120","author":"R Arora","year":"2013","unstructured":"Arora R, Manudhane A, Saran RK, Goyal J, Goyal G, Gupta D. Role of corneal collagen cross-linking in pseudophakic bullous keratopathy: a clinicopathological study. Ophthalmology. 2013;120(12):2413\u20138.","journal-title":"Ophthalmology"},{"issue":"5","key":"3521_CR91","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.4103\/ijo.IJO_1942_22","volume":"71","author":"M Singh","year":"2023","unstructured":"Singh M, Sinha BP, Mishra D, Deokar K, Bhatia G, Upreti G. Role of corneal collagen cross-linking in bullous keratopathy: a systematic review. Indian J Ophthalmol. 2023;71(5):1706\u201317.","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"3521_CR92","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000187630","volume":"41","author":"G Wollensak","year":"2009","unstructured":"Wollensak G, Aurich H, Wirbelauer C, Pham DT. Potential use of riboflavin\/UVA cross-linking in bullous keratopathy. Ophthalmic Res. 2009;41(2):114\u20137.","journal-title":"Ophthalmic Res"},{"issue":"9","key":"3521_CR93","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1097\/ICO.0000000000000176","volume":"33","author":"AJ Kanellopoulos","year":"2014","unstructured":"Kanellopoulos AJ, Asimellis G. Long-term safety and efficacy of high-fluence collagen crosslinking of the vehicle cornea in boston keratoprosthesis type 1. Cornea. 2014;33(9):914\u20138.","journal-title":"Cornea"},{"issue":"1","key":"3521_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-66629-2","volume":"14","author":"R Kilian","year":"2024","unstructured":"Kilian R, Schmidinger G, Lammer J. The role of graft cross-linking during keratoplasty in patients with corneal melting. Sci Rep. 2024;14(1):16026.","journal-title":"Sci Rep"},{"issue":"6","key":"3521_CR95","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/ICL.0000000000000081","volume":"40","author":"MC Robert","year":"2014","unstructured":"Robert MC, Arafat SN, Ciolino JB. Collagen cross-linking of the Boston keratoprosthesis donor carrier to prevent corneal melting in high-risk patients. Eye Contact Lens. 2014;40(6):376\u201381.","journal-title":"Eye Contact Lens"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03521-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03521-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03521-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:02:24Z","timestamp":1775728944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03521-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":95,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["3521"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03521-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Christopher J. Rapuano has nothing to disclose. Kenneth A. Beckman: Glaukos (consulting and contracted research). Oculus (consulting). Rajesh Rajpal: Glaukos\u2014Consultant\/Advisor. Other disclosures not relevant to manuscript: Horizon Surgical\u2014employee\/shareholder, Ufonia \u2013 investor. EyeDura\u2014investor. Lightfield Medical\u2014shareholder. Heru\u2013shareholder. SANNT\u2014investor\/consultant. Abbvie\u2014consultant. J&J\u2014former employee\/shareholder.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This narrative review was based on previously published studies, and no new studies involving human or animal participants were performed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}